Lucie Tixier

Clermont-ferrand, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 11 publications

Usefulness of an RNA extraction-free test for the multiplexed detection of ALK, ROS1, and RET Gene Fusions in Real Life FFPE Specimens of Non-Small Cell Lung Cancers.

Usefulness of an RNA extraction-free test for the multiplexed detection of ALK, ROS1, and RET Gene Fusions in Real Life FFPE Specimens of Non-Small Cell Lung Cancers.

Journal: Expert review of molecular diagnostics

Published: October 31, 2023

Neoadjuvant anthracycline-based (5-FEC) or anthracycline-free (docetaxel/carboplatin) chemotherapy plus trastuzumab and pertuzmab in HER2 + BC patients according to their TOP2A: a multicentre, open-label, non-randomized phase II trial.

Neoadjuvant anthracycline-based (5-FEC) or anthracycline-free (docetaxel/carboplatin) chemotherapy plus trastuzumab and pertuzmab in HER2 + BC patients according to their TOP2A: a multicentre, open-label, non-randomized phase II trial.

Journal: Breast cancer research and treatment

Published: October 18, 2023

Compliance to genomic test recommendations to guide adjuvant chemotherapy decision-making in the case of hormone receptor-positive, human epidermal growth factor receptor 2-negative breast cancer, in real-life settings.

Compliance to genomic test recommendations to guide adjuvant chemotherapy decision-making in the case of hormone receptor-positive, human epidermal growth factor receptor 2-negative breast cancer, in real-life settings.

Journal: Cancer medicine

Published: February 18, 2022

2021 update of the GEFPICS' recommendations for HER2 status assessment in invasive breast cancer in France

2021 update of the GEFPICS' recommendations for HER2 status assessment in invasive breast cancer in France

Journal: Annales de pathologie

Published: March 24, 2021

Multicenter harmonization study for PD-L1 IHC testing in non-small-cell lung cancer.

Multicenter harmonization study for PD-L1 IHC testing in non-small-cell lung cancer.

Journal: Annals of oncology : official journal of the European Society for Medical Oncology

Published: January 20, 2018

Analysis of tumour-infiltrating lymphocytes reveals two new biologically different subgroups of breast ductal carcinoma in situ.

Analysis of tumour-infiltrating lymphocytes reveals two new biologically different subgroups of breast ductal carcinoma in situ.

Journal: BMC cancer

Published: December 23, 2016

Strategy for molecular testing in pulmonary carcinoma

Strategy for molecular testing in pulmonary carcinoma

Journal: Annales de pathologie

Published: November 05, 2015

Assessment of the Relation between the Expression of Oxaliplatin Transporters in Colorectal Cancer and Response to FOLFOX-4 Adjuvant Chemotherapy: A Case Control Study.

Assessment of the Relation between the Expression of Oxaliplatin Transporters in Colorectal Cancer and Response to FOLFOX-4 Adjuvant Chemotherapy: A Case Control Study.

Journal: PloS one

Published: October 05, 2015

Giant mucinous cystic adenoma with pancreatic atrophy mimicking dorsal agenesis of the pancreas.

Giant mucinous cystic adenoma with pancreatic atrophy mimicking dorsal agenesis of the pancreas.

Journal: World journal of gastrointestinal surgery

Published: December 01, 2013

Fibrous tumours of the ovary: aetiologies and MRI features.

Fibrous tumours of the ovary: aetiologies and MRI features.

Journal: Clinical radiology

Published: May 28, 2013

Massive hepatic necrosis with toxic liver syndrome following portal vein ligation.

Massive hepatic necrosis with toxic liver syndrome following portal vein ligation.

Journal: World journal of gastroenterology

Published: November 16, 2012

Showing 1-11 of 11

Last Updated: 09/26/2026